Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
‘We are going to have difficulty’: Untangling causes of fatigue, long COVID remains elusive
Developing myalgic encephalomyelitis/chronic fatigue syndrome is significantly more likely after a case of COVID-19, an important connection for rheumatologists as they sort through symptoms and medical histories for a diagnosis, data show.
Study links SARS-CoV-2 infection with increase in chronic fatigue
Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome, an NIH-funded study showed.
Risk for myalgic encephalomyelitis/chronic fatigue syndrome no greater after COVID-19
COVID-19 does not increase patients’ risk for developing myalgic encephalomyelitis/chronic fatigue syndrome during the 1-year period post infection, according to a registry study published in JAMA Network Open.
‘There must be a persistent antigen’: NIH researcher discusses new PI-ME/CFS data
A recent NIH study of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome suggests that the condition is a “distinct entity,” with somatic and cognitive issues that are centrally mediated.